These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6153126)

  • 1. Measurements of prolactin and androgens in patients with prostatic diseases.
    Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
    Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
    Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
    J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls.
    Hulka BS; Hammond JE; DiFerdinando G; Mickey DD; Fried FA; Checkoway H; Stumpf WE; Beckman WC; Clark TD
    Prostate; 1987; 11(2):171-82. PubMed ID: 2444956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of prolactin and testosterone in the human prostate.
    Farnsworth WE; Slaunwhite WR; Sharma M; Oseko F; Brown JR; Gonder MJ; Cartagena R
    Urol Res; 1981; 9(2):79-88. PubMed ID: 6165128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
    Bartsch W; Horst HJ; Becker H; Nehse G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of serum levels of testicular steroid hormones to hCG stimulation in patients with prostatic cancer and benign prostatic hypertrophy.
    Isurugi K; Kanazawa M; Yanaihara T; Kambegawa A
    Prostate Suppl; 1981; 1():19-26. PubMed ID: 6176980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
    Vermeulen A; De Sy W
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    Habib FK; Lee IR; Stitch SR; Smith PH
    J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation.
    Bartsch W; Steins P; Becker H
    Eur Urol; 1977; 3(1):47-52. PubMed ID: 837954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of endocrine therapy on plasma steroids in prostatic carcinoma patients.
    Drafta D; Proca E; Schindler AE; Neacşu E; Zamfir V; Neagoe M; Teodosiu D
    Endocrinologie; 1984; 22(3):191-7. PubMed ID: 6494786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum steroids in normal males and patients with prostatic diseases.
    Hammond GL; Kontturi M; Vihko P; Vihko R
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):113-21. PubMed ID: 81115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
    Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
    Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
    Ghanadian R; Lewis JG; Chisholm GD; O'Donoghue EP
    Br J Urol; 1977 Nov; 49(6):541-4. PubMed ID: 73397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.
    Addo SB; Holland JF; Kirschenbaum A; Mandeli J; Hollander VP
    Steroids; 1990 Nov; 55(11):491-4. PubMed ID: 1706116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment hormone levels in prostatic cancer.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
    Taşar C; Akdaş A; Kirkali Z
    Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.